| CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
69
|
53 |
| GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
29
|
8 |
| RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
26
|
14 |
| PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
24
|
59 |
| CCND2-AS1 |
|
CCND2 antisense RNA 1
|
|
|
0.760 |
0.154 |
16
|
7 |
| ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
16
|
7 |
| LINC00511 |
|
long intergenic non-protein coding RNA 511
|
|
|
0.638 |
0.423 |
16
|
8 |
| OBI1-AS1 |
|
OBI1 antisense RNA 1
|
|
|
0.792 |
0.115 |
14
|
6 |
| LINC01475 |
|
long intergenic non-protein coding RNA 1475
|
|
|
0.780 |
0.077 |
14
|
6 |
| CASC8 |
|
cancer susceptibility 8
|
|
|
0.670 |
0.462 |
14
|
17 |
| CRTC3-AS1 |
|
CRTC3 antisense RNA 1
|
|
|
0.792 |
0.077 |
13
|
4 |
| LINC01500 |
|
long intergenic non-protein coding RNA 1500
|
|
|
0.760 |
0.192 |
12
|
16 |
| BAALC-AS1 |
|
BAALC antisense RNA 1
|
|
|
0.760 |
0.115 |
11
|
2 |
| CCAT2 |
|
colon cancer associated transcript 2
|
|
|
0.621 |
0.615 |
11
|
3 |
| LINC01121 |
|
long intergenic non-protein coding RNA 1121
|
|
|
0.751 |
0.192 |
11
|
12 |
| TENM3-AS1 |
|
TENM3 antisense RNA 1
|
|
|
0.780 |
0.192 |
11
|
3 |
| MZF1-AS1 |
|
MZF1 antisense RNA 1
|
|
|
0.792 |
0.077 |
10
|
1 |
| TMEM238L |
|
transmembrane protein 238 like
|
|
|
0.691 |
0.308 |
10
|
1 |
| LINC00446 |
|
long intergenic non-protein coding RNA 446
|
|
|
0.805 |
0.077 |
10
|
3 |
| TMEM220-AS1 |
|
TMEM220 antisense RNA 1
|
|
|
0.792 |
0.077 |
10
|
1 |
| FAM182A |
Q5T1J6
|
family with sequence similarity 182 member A
|
|
|
0.805 |
0.077 |
10
|
1 |
| LRP1-AS |
|
LRP1 antisense RNA
|
|
|
0.722 |
0.500 |
9
|
1 |
| LINC01173 |
|
long intergenic non-protein coding RNA 1173
|
|
|
0.805 |
0.077 |
9
|
1 |
| COLCA1 |
Q6ZS62
|
colorectal cancer associated 1
|
|
|
0.780 |
0.154 |
9
|
2 |